Sir,

Detection of alloantibodies is one of the main objectives of compatibility work-up before transplantation. One of the common strategies employed in India is to perform complement-dependent cytotoxicity cross-match (CDC) and flow cytometry-based cross-match (FCXM) tests.\[[@ref1]\] If either or both of these tests are positive, Luminex-based single antigen bead (SAB) assay is performed to identify specific antibodies. These antibodies are then matched with human-leukocyte antigens (HLA) of prospective donor to determine donor-specific antibody (DSA), called virtual cross-match.\[[@ref2]\] Routinely matching is done at antigen level; not at epitope level. Antibodies positive at antigen level can be negative at epitope level and vice versa.\[[@ref3][@ref4]\] Epitopes are configurations of polymorphic amino acid residues that are recognized by B cells, and antibodies reactive with these epitopes lead to rejection and/or premature allograft loss. we report our experience of two cases having history of sensitization, where class II (DPA1) antibody was ruled out as a DSA, only because of epitope analysis. Since this has a clinical implication of deciding the prospective kidney donor, epitope analysis may be used routinely in all SAB test interpretation.

Recipient serum samples were collected for Luminex SAB assay (LIFECODES LSA™ Kit Immucor Transplant Diagnostics, Inc. USA.) to identify the DSA. Luminex software (Match IT antibody) was used for antigen-based analysis (cut-off; BCM ≥1000/positive by machine) and Epitope-based analysis was done with the help of freely available online software \'HLA Matchmaker\' (<http://www.epitopes.net>).

As described in [Table 1](#T1){ref-type="table"}, we presented two cases where both the patients and prospective donors were females, having history of sensitization. All three tests (CDCXM, FCXM, and SAB) were performed for pre-transplant workup. In the first case, CDC cross-match was negative and FCXM was positive for both T and B cells and in the second case CDC and B cell FCXM were negative; T cell FCXM was positive. DSA was identified in class I and class II in both cases. DSA allele matching at antigen and epitope level was performed. In both cases, epitope analysis revealed that antibody against DP locus was not DSA.

###### 

HLA typing, pretransplant compatibility testing, and DSA on the basis of epitope matching.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
            HLA typing      CDC     FCXM    DSA antigen matching   Epitope matching   Result after epitope analysis                                                                                                                                                                            
  --------- --------------- ------- ------- ---------------------- ------------------ ------------------------------- ------- ------ ----- ----- ----- ---------- ------ -------------------------- --------- -------------------------------------------------------------------------------- ----------------------------------------------------------
  Case 1    Recipient       A\      B\      DR\                    DQA\               DQB\                            DPA\    DPB\   -VE   +VE   +VE   Alleles\   MFI\   Alleles\                   MFI\      B\*44:03 (Epitope 162GLS) DRB1\*10:01 (Epitope 13FE)DPB1\*04:01 (Epitope 33EA)   1\) No DSA in DP locus.2) DSA found in B and DRB1 locus.
                            02,11   13,18   07,11                  ND                 ND                              ND      ND                       B\*44:03   1018   DRB1\*10:01\               5349\                                                                                      
                                                                                                                                                                         DPA1\*02:01-DPB1\* 04:01   1930                                                                                       

  Age/Sex   Sensitization                                                                                                                                                                                                                                                                      

  47/F      Yes                                                                                                                                                                                                                                                                                

  Donor     A\              B\      DR\     DQ\                    DQ\                DPA\                            DPB\                                                                                                                                                                     
            02,11           13,44   07,10   AND                    BND                02,02                           17,26                                                                                                                                                                    

  Age/Sex   Relationship                                                                                                                                                                                                                                                                       

  27/F      Daughter                                                                                                                                                                                                                                                                           

  Case 2    Recipient       A\      B\      DR\                    DQ\                DQ\                             DP\     DP\    -VE   +VE   -VE   Alleles\   MFI\   Alleles\                   MFI3344   B\*44:02 (Epitope 82LR + 145R) DPB1\*06:01 (Epitope 84DEAV)                      1\) No DSA in DP locus.2.) DSA found in B locus.
                            02,11   13,18   07,11                  AND                BND                             AND     BND                      B\*44:02   1694   DPA1\*01:03-DPB1 \*06:01                                                                                              

  Age/Sex   Sensitization                                                                                                                                                                                                                                                                      

  30/F      Yes                                                                                                                                                                                                                                                                                

  Donor     A\              B\      DR\     DQA\                   DQB\               DPA\                            DPB\                                                                                                                                                                     
            02,02           40,44   15,15   01,01                  06,06              01,01                           02,04                                                                                                                                                                    

  Age/Sex   Relationship                                                                                                                                                                                                                                                                       

  54/F      Mother                                                                                                                                                                                                                                                                             
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CDC: Complement-dependent cytotoxicity cross-match; FCXM: Flow cytometry-based cross-match; DSA: Donor-specific antibodies

Both these patients had significant DSA in class I (case I - B\*44:03 and case II - B\*44:02) and class II (case I-DRB1\*10:01; DPA1\*02:01- DPB1\*04:01 and case II DPA1\*01:03-DPB1\*06:01). Case 2 underwent desensitization by therapeutic plasma exchange (TPE) followed by retesting for median fluorescence intensity MFI. The patient (case 2) underwent successful renal transplant once MFI below 500\[[@ref5]\] was achieved. However, what we would like the readers of journal know that if we had considered antigen-based analysis only and if these Class II (case I- DPA1\*02:01-DPB1\*04:01 and case II; DPA1\*01:03-DPB1\*06:01) were the only antibodies present in the recipient; it would have led to donor deferral. The epitope-based analysis resolved that DPA1\*02:01- DPB1\*04:01 in case I and DPA1\*01:03-DPB1\*06:01 in case II were not DSA and these patients could have undergone successful transplant even without TPE. India is a predominantly live-related transplant setting where only close relatives can be organ donors as per Transplantation of Human Organs and Tissues Act (THOTA) 2014.\[[@ref6]\] To have a willing donor in the family, by itself is difficult and any unnecessary deferral would be catastrophic for the recipient and her/his family. It is in this light, that epitope-based analysis assumes even greater significance.
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